Save up to 85% with generic and 65% with brand Breo Ellipta inhalers. Breo Ellipta is called Revlar Ellipta in Europe.
Information about Breo Ellipta (fluticasone/vilanterol)
Breo Ellipta is a prescription medication used primarily for the management of chronic obstructive pulmonary disease (COPD) and asthma. It is a combination inhaler that contains two active ingredients: fluticasone propionate and vilanterol.
Fluticasone is a corticosteroid that helps reduce inflammation in the airways, while vilanterol is a long-acting beta-agonist (LABA) that helps relax the muscles around the airways, making it easier to breathe.
Product Highlights
- Breo Ellipta combines a corticosteroid and a long-acting beta-agonist in a single inhaler.
- It is designed for once-daily use, which can improve adherence and simplify the treatment regimen.
- The medication comes in a pre-measured, easy-to-use inhaler device called the Ellipta inhaler.
- Fluticasone Propionate a corticosteroid that reduces inflammation and swelling in the airways.
- Vilanterol a long-acting beta-agonist that helps relax airway muscles to improve airflow.
Key Ingredient
- Fluticasone Propionate
- Vilanterol
Key Benefits
- Helps to open airways and improve breathing by reducing inflammation and relaxing airway muscles.
- Helps manage chronic symptoms of asthma and COPD, such as wheezing, shortness of breath, and coughing.
- The once-daily dosing can make it easier for patients to remember to take their medication.
Direction of Use
- Available for oral inhalation only.
- Treatment of COPD: 1 inhalation of BREO ELLIPTA 100/25 once daily.
- Treatment of Asthma: 1 inhalation of BREO ELLIPTA 100/25 or BREO ELLIPTA 200/25 once daily.
Safety Concerns
- Common side effects can include throat irritation, cough, headache, and possible oral thrush. Rare but serious side effects may include allergic reactions, paradoxical bronchospasm, and worsening of asthma symptoms.
- Long-term use of corticosteroids can affect the adrenal glands. Regular monitoring may be necessary.
- Prolonged use may affect bone density, so bone health should be monitored if using for an extended period.
Avoid Breo Ellipta (fluticasone/vilanterol) If
- If you have a known allergy to fluticasone, vilanterol, or any other component of the inhaler.
- For acute asthma attacks or COPD exacerbations, a rescue inhaler (short-acting beta-agonist) is more appropriate.
- If you have specific health conditions such as tuberculosis, fungal infections, or untreated infections, as these could be worsened by corticosteroid use.
- Consult with a healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of Breo Ellipta in these situations should be evaluated.
